Benitec Biopharma Inc. · NASDAQ:BNTC
Montanova Capital, LLC reported a 44.10% stake in Benitec Biopharma Inc. (Schedule 13D/A)
Event Nov 7, 2025 · Filed Nov 10, 2025
Montanova Capital, LLC reported a 44.10% stake in Benitec Biopharma Inc., 17,761,945 shares, with active intent on Nov 7, 2025. Filed Nov 10, 2025 (Schedule 13D/A).
- Stake
- 44.10%
- Shares
- 17,761,945
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 44.10% | 17,761,945 |
| Averill Master Fund, Ltd. | 37.80% | 15,237,643 |
| Averill Madison Master Fund, Ltd. | 6.30% | 2,524,302 |
| Aaron Cowen | 44.10% | 17,761,945 |
Source
Related
- Benitec Biopharma Inc.
- Montanova Capital, LLC
- Benitec Biopharma Inc. shareholders
- Schedule 13D/A · Montanova Capital, LLC · Mar 28, 2025
- Form 4 · Buchi J Kevin · Jun 30, 2026
- Schedule 13G/A · Franklin Resources Inc · Jan 29, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Dec 8, 2025
- Schedule 13G · Ra Capital Management, L.P. · Dec 3, 2025
- Schedule 13G/A · Franklin Resources Inc · Nov 4, 2025